Viyash Scientific Limited (VIYASH) — Financial Results | 12 August 2026 (2 announcements)

12 August 2026 · NSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

1Financial Results🔴 High Importance Neutral📄 PDF

📢 Key Event

Audio recording of earnings call released

💡 Investor Takeaway

Investors can now listen to the earnings call to review management commentary on Q1 2026 results.

Viyash Scientific Limited announced the audio recording of its earnings call for the quarter ended June 30, 2026, held on August 12, 2026, available on its website for investors to access.

2Financial Results🔴 High Importance Neutral📄 PDF

📢 Key Event

Viyash Scientific presented Q1 FY27 financial results and Bio For Life acquisition progress

🔄 What Changed

Revenue grew 19.5% YoY to ₹9,464 million; EBITDA rose 59.2% YoY to ₹2,047 million; net debt was ₹1,661 million

🔮 What's Next

Acquisition of Bio For Life in Italy expected to close by September 2026

💡 Investor Takeaway

Shareholders gain from strong revenue and EBITDA growth driven by integration and European market expansion

Viyash Scientific reported Q1 FY27 standalone revenue of ₹9,464 million, up 19.5% YoY, with EBITDA at ₹2,047 million (+59.2% YoY) and net debt of ₹1,661 million. The company highlighted integration progress, acquisition of Bio For Life in Italy, and expansion in companion animal markets. Gross margin improved to 54.1%, and EBITDA margin rose to 21.6%. The investor presentation emphasized operational efficiency and strategic growth in European and emerging markets.

📊 Stock Analysis — VIYASH ✨ Ask AI About This

About Viyash Scientific Limited (VIYASH)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹10,303.71 CrP/E: 38.6ROE: 7.5%ROCE: 14.6%

View full VIYASH stock details →

📡 Get AI alerts when VIYASH files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track VIYASH — Free

💡 Ask AI about this filing

"When will the full earnings report be published?""What were the key drivers of Q1 2026 revenue growth?""How does management view profitability trends for the next quarter?"

Ask AI Free →

📊 More VIYASH filings

🔴 Corporate Action — 1 October 2026Viyash Scientific completed its acquisition of 100% of BioForLife Italia S.r.l. on October 1, 2026, ...
Announcement — 28 September 2026Viyash Scientific Limited announced that its trading window will close on October 1, 2026, and remai...
🔴 Corporate Action — 18 September 2026Viyash Scientific announced the allotment of 11,07,309 equity shares under its ESOP 2020 and ESOP 20...
🔴 Announcement — 8 September 2026Viyash Scientific announced that Italian regulatory approval for its proposed acquisition of BioForL...
🔴 Corporate Action — 4 September 2026Viyash Scientific announced the allotment of 612,773 equity shares under its 2020 and 2026 employee ...

See all VIYASH filings →

🔥 Also filed on 12 August 2026

DBLDilip Buildcon LimitedCorporate Action NITCONitco LimitedFinancial Results KPIGREENKPI Green Energy LimitedFinancial Results SDBLSom Distilleries & Breweries LimitedFinancial Results CONSOFINVTConsolidated Finvest & Holdings LimitedCorporate Action TOUCHWOODTouchwood Entertainment LimitedFinancial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when VIYASH files new disclosures

Track VIYASH filings, board meetings, and corporate actions. Free email alerts at 5 PM.